OSE Immunotherapeutics Announces Participation In Upcoming Investor Conferences
Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announced today that the leadership team will attend several investor conferences in September and October 2022. Conference